World Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.

Press releases published on May 4, 2026

May 4, 2026

4DMT to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

May 4, 2026

Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD

Indeterminate GlobeNewswire

May 4, 2026

Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems

Indeterminate GlobeNewswire

May 4, 2026

Bascom Palmer Eye Institute Presents Four Posters on Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2026, Advancing the Clinical Case for Provectus’s VisiRose Subsidiary and Rose Bengal Sodium in Infectious Keratitis

Indeterminate GlobeNewswire

May 4, 2026

HealthLynked Launches New Consumer Platform and Multi-Site Digital Ecosystem to Redefine the Front Door to Healthcare

Indeterminate GlobeNewswire

May 4, 2026

Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton

Indeterminate GlobeNewswire

May 4, 2026

LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference

Indeterminate GlobeNewswire

May 4, 2026

Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

May 4, 2026

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

Indeterminate GlobeNewswire

May 4, 2026

Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology

Indeterminate GlobeNewswire

May 4, 2026

Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth

Indeterminate GlobeNewswire

May 4, 2026

Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million

Indeterminate GlobeNewswire

May 4, 2026

Emerging Drugs Market to Reach $558.0 Billion by 2030, Driven by Biologics Innovation and Regulatory Support

Indeterminate GlobeNewswire

May 4, 2026

Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference

Indeterminate GlobeNewswire

May 4, 2026

MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement

Indeterminate GlobeNewswire

May 4, 2026

Entente Education Canada honours Dr. Roger Wong with Award for Eminent Contribution to Older Adults in Canada

Indeterminate GlobeNewswire

May 4, 2026

BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026

Indeterminate GlobeNewswire

May 4, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 4, 2026

Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas

Indeterminate GlobeNewswire

May 4, 2026

InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes

Indeterminate GlobeNewswire